Advisory Committee on Immunization Practices, 36188 [05-12293]

Download as PDF 36188 Federal Register / Vol. 70, No. 119 / Wednesday, June 22, 2005 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Technical Evaluation Panel (TEP): Pilot FollowUp of Former Workers at Vermiculite Processing Sites in the United States, Contract Solicitation Number #0000HTB8–2005–19635 Advisory Committee on Immunization Practices In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Advisory Committee on Immunization Practices (ACIP). Times and Dates: 8 a.m.–6:45 p.m., June 29, 2005;8 a.m.–3:35 p.m., June 30, 2005. Place: Atlanta Marriott Century Center, 2000 Century Boulevard, NE., Atlanta, Georgia 30345–3377. Status: Open to the public, limited only by the space available. Purpose: The Committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters To Be Discussed: The agenda will include discussions on pertussis adolescent recommendation and use in adults; Hepatitis B vaccine recommendation; recommendations of use of Hepatitis A vaccine and possibleVFC vote; Measles, Mumps, Rubella, and Varicella VirusVaccine (MMRV): Overview of varicella epidemiology and possible VFC votes on second dose varicella and MMRV; summary of American Academy of Pediatrics recommendations; Human Papilloma Virus vaccine working group update; general recommendations: vaccine storage and handling; adult immunization schedule; Advisory Committee on Immunization Practices and National Vaccine Advisory Committee joint working group and the preliminary results on pandemic vaccine prioritization; Advisory Committee on ImmunizationPractices and Healthcare Infection Control PracticesAdvisory Committee joint statement on immunization of health care workers against influenza; rotavirus; HIV vaccine update; and Departmental updates. Contact Person for more Information: Demetria Gardner, Epidemiology and Surveillance Division, NationalImmunization Program, CDC, 1600 Clifton Road, NE., (E– 61),Atlanta, Georgia 30333, telephone 404/ 639–8096, fax 404/639–8616. Due to programmatic issues that had to be resolved, the Federal Register notice is being published less than fifteen days before the date of the meeting. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and Name: Disease, Disability, and Injury Prevention and Control Technical Evaluation Panel (TEP): Pilot Follow-Up of Former Workers at Vermiculite Processing Sites in the United States, Contract Solicitation Number #0000HTB8–2005–19635. Times and Dates: 11:30 a.m.–12 p.m., July 7, 2005 (Open); 12 p.m.–3 p.m., July 7, 2005 (Closed). Place: Teleconference (404) 498–0003. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to: Pilot Follow-Up of Former Workers at Vermiculite Processing Sites in the United States, Contract Solicitation Number #0000HTB8–2005–19635. Contact Person for More Information: Mildred Williams-Johnson, Ph.D., D.A.B.T., Health Science Administrator, National Center for Environmental Health, CDC, 1600 Clifton Road NE., Mailstop E28, Atlanta, GA 30333, Telephone (404) 498–0639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 16, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–12296 Filed 6–21–05; 8:45 am] BILLING CODE 4163–18–P VerDate jul<14>2003 21:12 Jun 21, 2005 Jkt 205001 In accordance with section 10(a)(2) of the FederalAdvisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Federal Committee meeting. PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 other committee management activities for both the CDC and ATSDR. Dated: June 16, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–12293 Filed 6–21–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Advisory Board on Radiation and Worker Health In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting: Name: Advisory Board on Radiation and Worker Health(ABRWH), National Institute for Occupational Safety andHealth (NIOSH) and Subcommittee for Dose Reconstruction andSite Profile Reviews. Subcommittee Meeting Times and Dates: 7:30 a.m.–8:30 a.m., July 6, 2005. 7:30 a.m.–9 a.m., July 7, 2005. Committee Meeting Times and Dates: 1 p.m.–6 p.m., July 5, 2005. 7:30 p.m.–9 p.m., July 5, 2005. 8:30 a.m.—5:30 p.m., July 6, 2005. 9 a.m.–4:15 p.m., July 7, 2005. 4:15 p.m.–5:45 p.m., July 7, 2005. Place: Chase Park Plaza Hotel, 212–232 N. Kingshighway Blvd., St. Louis, Missouri 63108, telephone: 314–633–1000, fax: 314– 633–1144. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 200 people. Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) of 2000 to advise the President, delegated to the Secretary of Health and Human Services (HHS), on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Board include providing advice on the development of probability of causation guidelines which have been promulgated by HHS as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Board to HHS, which subsequently delegated this E:\FR\FM\22JNN1.SGM 22JNN1

Agencies

[Federal Register Volume 70, Number 119 (Wednesday, June 22, 2005)]
[Notices]
[Page 36188]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-12293]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices

    In accordance with section 10(a)(2) of the FederalAdvisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal Committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8 a.m.-6:45 p.m., June 29, 2005;8 a.m.-3:35 
p.m., June 30, 2005.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: The agenda will include discussions on 
pertussis adolescent recommendation and use in adults; Hepatitis B 
vaccine recommendation; recommendations of use of Hepatitis A 
vaccine and possibleVFC vote; Measles, Mumps, Rubella, and Varicella 
VirusVaccine (MMRV): Overview of varicella epidemiology and possible 
VFC votes on second dose varicella and MMRV; summary of American 
Academy of Pediatrics recommendations; Human Papilloma Virus vaccine 
working group update; general recommendations: vaccine storage and 
handling; adult immunization schedule; Advisory Committee on 
Immunization Practices and National Vaccine Advisory Committee joint 
working group and the preliminary results on pandemic vaccine 
prioritization; Advisory Committee on ImmunizationPractices and 
Healthcare Infection Control PracticesAdvisory Committee joint 
statement on immunization of health care workers against influenza; 
rotavirus; HIV vaccine update; and Departmental updates.
    Contact Person for more Information: Demetria Gardner, 
Epidemiology and Surveillance Division, NationalImmunization 
Program, CDC, 1600 Clifton Road, NE., (E-61),Atlanta, Georgia 30333, 
telephone 404/639-8096, fax 404/639-8616.
    Due to programmatic issues that had to be resolved, the Federal 
Register notice is being published less than fifteen days before the 
date of the meeting.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and ATSDR.

    Dated: June 16, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-12293 Filed 6-21-05; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.